The U.S. Food and Drug Administration (FDA) issued a final rule in 2016 prohibiting the marketing of consumer antiseptic washes containing triclosan and 18 other specific active ingredients. The agency determined manufacturers failed to prove these products were both safe for daily use and more effective than plain soap and water.
Regulatory Action Against Triclosan
For decades, triclosan and triclocarban were ubiquitous in liquid soaps, body washes, and sanitizers. These chemicals were designed to kill bacteria on the skin, but their widespread use triggered significant scrutiny regarding long-term human health and environmental impacts. The FDA’s regulatory process for these products falls under the Monograph system, which evaluates the safety and effectiveness of non-prescription drug ingredients. Under this framework, ingredients are classified into three categories: Category I (generally recognized as safe and effective), Category II (not generally recognized as safe and effective), and Category III (insufficient data to make a determination).
In its 2016 ruling, the FDA concluded that there was no scientific evidence that over-the-counter (OTC) antibacterial soaps were better at preventing illness or the spread of infections than washing with regular soap and water. The agency cited a lack of data to support the long-term safety of daily exposure to these chemicals, specifically noting concerns about potential endocrine disruption and the development of antibiotic-resistant bacteria. The final rule specifically targeted consumer antiseptic wash products, which include hand washes and body washes used with water. It did not apply to hand sanitizers, which are typically alcohol-based, or to products used in healthcare settings, such as hospitals or nursing homes, where different regulatory standards and clinical needs apply.
The Mechanism of Antibiotic Resistance
The primary scientific concern regarding antibacterial soaps is the risk of “cross-resistance.” When bacteria are exposed to sub-lethal concentrations of biocides like triclosan, they may undergo genetic changes that also make them resistant to clinically important antibiotics. This occurs because many biocides and antibiotics target similar cellular pathways within bacteria. If a bacterium survives a low-level exposure to a chemical agent, it may develop mechanisms—such as efflux pumps that expel harmful substances or modifications to its cell wall—that subsequently protect it from pharmaceutical-grade antibiotics.
Dr. Stuart Levy, a professor at Tufts University School of Medicine and a pioneer in antibiotic resistance research, long argued that the use of these agents in consumer products creates an unnecessary selective pressure on microbial populations. According to the Centers for Disease Control and Prevention (CDC), the overuse of antimicrobial agents in the environment contributes to the broader crisis of antimicrobial resistance (AMR), where bacteria evolve to survive drugs intended to kill them. This global health threat complicates the treatment of common infections, potentially rendering standard medical procedures more dangerous and increasing the duration and cost of hospital stays.
Current Market Status and Consumer Safety
Following the 2016 FDA mandate, companies were required to remove the banned ingredients from their products or reformulate them entirely. While these specific chemicals are no longer permitted in consumer soaps, they may still be found in other settings, such as hospital-grade disinfectants or specific industrial applications where their use is regulated under different standards. The FDA’s action was a culmination of years of review, reflecting a shift in regulatory philosophy toward requiring proactive proof of safety for chemicals that are used daily by the general population.
The CDC currently emphasizes that the most effective way to prevent the spread of germs is thorough handwashing with plain soap and water for at least 20 seconds. This mechanical process physically removes pathogens from the skin without introducing chemical agents that could promote bacterial mutation. The agency notes that the lathering and rinsing action is the critical component of hand hygiene, as it dislodges germs from the skin surface, allowing them to be washed down the drain.
Understanding the Risks of Over-Sanitization
Beyond the threat of superbugs, the medical community remains cautious about the impact of antibacterial products on the human microbiome. Research published in the journal mBio has explored how the elimination of commensal bacteria—the “good” microbes that live on our skin—can potentially disrupt the skin’s natural barrier. These commensal organisms play an essential role in training the immune system and preventing the colonization of pathogenic bacteria. Excessive use of broad-spectrum biocides can strip the skin of this protective layer, potentially increasing susceptibility to skin conditions or infections.
The use of antibacterial products by the general public does not provide a benefit over the use of plain soap and water and may pose a risk to human health.
While the 2016 rule addressed the most common offenders, consumers should remain aware of product labels. The FDA continues to monitor the safety of other ingredients used in personal care products. Consumers interested in the specific active ingredients in their soaps can review the “Drug Facts” label on the back of the packaging. If you have concerns about the ingredients in your personal care products or the potential for allergic reactions, consult your healthcare provider or a board-certified dermatologist for guidance on appropriate cleansing routines tailored to your specific skin needs and health history.
Find more reporting in our Health section.
